The Lankenau Institute for Medical Research
Grant Awards
Lankenau Institute researchers compete for grants nationally and locally
from federal and state funding agencies such as the National Institutes
of Health (NIH) as well as through private and family foundations. The
grants listed below represent some of the funding that has been awarded
to our investigators.
|
Funding Agency |
Project |
Principal Investigator |
Project Period |
Grant Award |
| NIH |
IDO2 Targeting for Pancreatic Cancer Treatment |
G. Prendergast | 09/11 - 08/12 | $401,141 |
|
Susan G. Komen for The Cure |
Immune-Based Suppression of Breast Cancer Metastasis by Targeting IDO |
A. Muller | 08/11 - 08/14 | $599,774 |
| NIH |
IDO Inhibitors for Combinatorial Cancer Therapy |
G. Prendergast | 08/11 - 05/16 | $1,278,315 |
| NIH |
Human Monoclonal Antibodies that Bind Botulinum Toxins |
S. Dessain | 02/11 - 01/15 | $1,956,691 |
| NIH |
|
L. Mandik-Nayak | 07/10 - 04/15 | $1,796,850 |
|
|
|
|
|
|
| NIH |
Polyamines and |
S. Gilmour |
12/06 -7/12 |
$1,576,426 |
